NMPA Extends Validation Period for COVID-19 Antigen Detection Reagents

The National Medical Products Administration released a notification extending the validation period of approvals for COVID-19 antigen detection reagents for another six months.

Current Approvals and Future Plans
The NMPA has approved 36 COVID-19 antigen detection reagents for marketing in China, with more to come.-Fineline Info & Tech

Insight, China's Pharmaceutical Industry